Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson’s disease.

To evaluate short-term efficacy and safety of fesoterodine fumarate in Parkinson’s disease (PD) patients with overactive bladder (OAB) symptoms.

This is a randomized, double-blind, placebo-controlled study.